Back
Relmada Therapeutics Stock Price Chart
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the corner
Sell
45
RLMD
Relmada Therapeutics
Last Price:
3.91
Seasonality Move:
-13.88%
7 Day Trial
ALL ACCESS PASS
$
7
The little-known AI stock you need to read about now...
Get the name - FREE.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RLMD is experiencing slight selling pressure.
Relmada Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.72 | Buy |
| 20-day SMA: | 4.05 | Sell |
| 50-day SMA: | 4.84 | Sell |
| 200-day SMA: | 3.72 | Buy |
| 8-day EMA: | 3.79 | Buy |
| 20-day EMA: | 4.03 | Sell |
| 50-day EMA: | 4.4 | Sell |
| 200-day EMA: | 4.43 | Sell |
Relmada Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.3 | Sell |
| Relative Strength Index (14 RSI): | 40.35 | Sell |
| Chaikin Money Flow: | -5443 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.74 - 4.62) | Sell |
| Bollinger Bands (100): | (3.39 - 5.51) | Sell |
Relmada Therapeutics Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Relmada Therapeutics Stock
Is Relmada Therapeutics Stock a Buy?
- Relmada Therapeutics share price is 3.82 while RLMD 8-day simple moving average is 3.72, which is a Buy signal.
- The stock price of RLMD is 3.82 while Relmada Therapeutics 20-day SMA is 4.05, which makes it a Sell.
- Relmada Therapeutics 50-day simple moving average is 4.84 while RLMD share price is 3.82, making it a Sell technically.
- RLMD stock price is 3.82 and Relmada Therapeutics 200-day simple moving average is 3.72, creating a Buy signal.
RLMD Technical Analysis vs Fundamental Analysis
Sell
45
Relmada Therapeutics (RLMD)
is a Sell
Is Relmada Therapeutics a Buy or a Sell?
-
Relmada Therapeutics stock is rated a Sell
The current Relmada Therapeutics [RLMD] share price is $3.82. The Score for RLMD is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Relmada Therapeutics Stock Info
Market Cap:
115.27M
Price in USD:
3.82
Share Volume:
59.87K
Relmada Therapeutics 52-Week Range
52-Week High:
7.22
52-Week Low:
2.36
Sell
45
Relmada Therapeutics (RLMD)
is a Sell
Relmada Therapeutics Share Price Forecast
-
What is the Relmada Therapeutics stock price today?
The Relmada Therapeutics stock price is 3.82 USD today. -
Will RLMD stock go up or go down?
Relmada Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Relmada Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Relmada Therapeutics is overvalued.
Is Relmada Therapeutics Stock a Buy?
- Relmada Therapeutics share price is 3.82 while RLMD 8-day exponential moving average is 3.79, which is a Buy signal.
- The stock price of RLMD is 3.82 while Relmada Therapeutics 20-day EMA is 4.03, which makes it a Sell.
- Relmada Therapeutics 50-day exponential moving average is 4.40 while RLMD share price is 3.82, making it a Sell technically.
- RLMD stock price is 3.82 and Relmada Therapeutics 200-day simple moving average is 4.43, creating a Sell signal.
Fundamental Analysis of Relmada Therapeutics
Is Relmada Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and an increase next year of $0.39 per share.
Technical Analysis of Relmada Therapeutics
Should I short Relmada Therapeutics stock?
- RLMD Moving Average Covergence Divergence (MACD) indicator is -0.3, suggesting Relmada Therapeutics is a Sell
- Relmada Therapeutics Relative Strength Index (RSI) is 40.35, which suggest Relmada Therapeutics is oversold
- The Bollinger Bands (25) for Relmada Therapeutics is (3.74 - 4.62), which suggest Relmada Therapeutics is a Sell
- The Bollinger Bands (100) for Relmada Therapeutics is (3.39 - 5.51), which suggest Relmada Therapeutics is a Sell
* Relmada Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.